Short answer
Neuronetics, Inc. (STIM) filed an 8-K current report with the SEC on March 17, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Q4 and full-year 2025 earnings released March 17, 2026: covering period ended December 31, 2025.
Neuronetics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 earnings released March 17, 2026: covering period ended December 31, 2025
- Full financial details in Exhibit 99.1 press release; key figures not disclosed in this filing item
Item 5.02 · Departure/Election of Directors or Officers
- New CEO Daniel Reuvers starts March 23, 2026; age 63 with 35+ years medtech experience including CEO of Tactile Medical (TCMD) 2020–2024
- Base salary $730,000 with target annual bonus at 100% of base salary (~$730,000 target total cash)
- Equity grant of 1,500,000 RSUs vesting equally over 3 years (500,000 units/year): significant retention incentive
- Severance package includes 12 months base salary + prorated target bonus if terminated without cause or for good reason
- Prior track record includes leading Integra's $1B Codman neurosurgical segment; two successful private company exits: suggests operational credibility in medtech
Item 7.01 · Regulation FD Disclosure
- Forward-looking statements cover revenue, expenses, growth outlook for upcoming quarters and full-year fiscal 2026
- Key risk flags: reliance on NeuroStar system for all revenue, history of losses, ability to maintain positive cash flow
- Credit facility terms and self-sustainability of existing cash balances cited as specific financial risks
- Greenbrook TMS integration risk highlighted: potential effects on business relationships and operating results
- Better Me Provider Program rollout timeline flagged as execution risk worth monitoring for commercial traction signals
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Neuronetics, Inc. 8-K filings
Get the next STIM 8-K as it lands
Follow STIM for push alerts, or ask the research agent what this filing means.